A highly sensitive screening system to evaluate the reversibility of neuroendocrine prostate cancer to prostate adenocarcinomaTomohiro Fukui(Kyoto University), Shusuke Akamatsu(Kyoto University)Cancer MedicineFebruary 27, 202510.1002/cam4.70047Cited by 1SaveCiteExport RISWatch citationsRelated PapersExtracellular vesicles secreted from bone metastatic renal cell carcinoma promote angiogenesis and endothelial gap formation in bone marrow in a time-dependent manner in a preclinical mouse model|Frontiers in Oncology|2023|7Case Report: Genomic insights into prostate adenocarcinoma transdifferentiation to carcinosarcoma due to lineage plasticity|Frontiers in Oncology|2025|0